Paradigm Biopharma
  • About Us
    • At a glance
    • Leadership
  • Paradigm shift
    • A different angle
    • Repurposing
  • Our focus
    • Addressing an unmet need
    • PPS
    • Lead indications
  • Partners
    • Strategic partners
  • Investors
    • Current share price
    • Corporate Governance
    • ASX Announcements
    • Presentations
    • Annual reports
    • Media / analyst reports
    • IP Patents / Trademarks
    • Peer reviewed publications
  • Contact
Press enter to begin your search

Recent Presentations

2021 presentations

39th Annual JP Morgan Healthcare Conference Presentation 

2020 presentations

R&D Day Presentation 2020
R&D DAY – LUMI Online Meeting Guide
Paradigm Virtual AGM 2020
Bell Potter Emerging Leaders Conference
EAP Film
EAP Results Presentation
Paradigm CEO Paul Rennie hosts an investor call to discuss US FDA Regulatory Pathway, latest SAS real world data and capital raising process, 8th April 2020
Listen to audio hereListen to audio here
CEO Paul Rennie, NWR Small Cap Virtual Conference, 27th March; Presentation slide deck
CEO Paul Rennie, NWR Small Cap Virtual Conference, 27th March; video recording
Paradigm MPS VI poster – World Symposium, Orlando, Florida

2019 presentations

Paradigm AGM Presentation Nov 2019

2018 presentations

Phase 2b OA/BME Clinical Trial Results Presentation
Professor Jegan Krishnan, presentation to the International Society for Knowledge for Surgeons on Arthroscopy and Arthroplasty (ISKSAA), Leeds, UK (June)

About

Paradigm Biopharmaceuticals is a drug repurposing company approaching unmet needs from a completely different angle. We are developing new solutions by identifying under-utilised molecules and unlocking their full value.

Links

  • Home
  • About Us
  • Contact
  • Investors
  • Our focus
  • Paradigm shift
  • Partners

Contact

For general enquiries, or enquiries about our investigational products, please contact us at:

info@paradigmbiopharma.com

© 2020 Paradigm Biopharmaceuticals Ltd | All rights reserved | Privacy Policy | Terms Of Use

  • About Us
    • At a glance
    • Leadership
  • Paradigm shift
    • A different angle
    • Repurposing
  • Our focus
    • Addressing an unmet need
    • PPS
    • Lead indications
  • Partners
    • Strategic partners
  • Investors
    • Current share price
    • Corporate Governance
    • ASX Announcements
    • Presentations
    • Annual reports
    • Media / analyst reports
    • IP Patents / Trademarks
    • Peer reviewed publications
  • Contact